Summary
The CYP17 gene codes for the cytochrome P450c17α enzyme that is involved in the synthesis of oestrogens. This case-control study from the South East of Scotland shows that a polymorphism of the CYP17 gene is associated with an increased risk of male breast cancer.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Brentano, ST, Picado-Leonard, J, Mellon, SH, Moore, CCD & Miller, WL (1990). Tissue-specific, cyclic adenosine 3′,5′ -monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4: 1972–1979.
Carey, AH, Waterworth, D, Patel, K, White, D, Little, J, Novelli, P, Franks, S & Williamson, R (1994). Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3: 1873–1876.
Dunning, AM, Healey, CS, Pharoah, PDP, Foster, NA, Lipscombe, JM, Redman, KL, Easton, DF, Day, NE & Ponder, BAJP (1998). No association between a polymorphism in the steroid metabolism gene Cyp17 and risk of breast cancer. Br J Cancer 77: 2045–2047.
Feigelson, HS, Ross, RK, Yu, MC, Coetzee, GA, Reichardt, JKV & Henderson, BE (1996). Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem, Suppl 25: 15–22.
Feigelson, HS, Coetzee, GA, Kolonel, LN, Ross, RK & Henderson, BE (1997). A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57: 1063–1065.
Feigelson, HS, Shames, LS, Pike, MC, Coetzee, GA, Stanczyk, FZ & Henderson, BE (1998). Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 58: 585–587.
Friedman, LS, Gayther, SA, Kurosaki, T, Gordon, D, Noble, B, Casey, G, Ponder, BAJP & Anton-Culver, H (1997). Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60: 313–319.
Jackson, AW, Muldal, S, Ockey, CH & O’Connor, PJ (1965). Carcinoma of the male breast in association with the Klinefelter syndrome. Br Med J 1: 223–225.
Lobaccaro, JM, Lumbroso, S, Belon, C, Galtier-Dereure, F, Bringer, J, Lesimple, T, Heron, JF, Pujol, H & Sultan, C (1993). Male breast cancer and the androgen receptor gene (Letter). Nat Genet 5: 2109–110.
Miki, Y, Swensen, J, Shattuck-Eidens, D, Futreal, PA, Harshman, K, Tavtigian, S, Liu, Q, Cochran, C, Bennett, LM, Ding, W, Bell, R, Rosental, J, Hussey, C, Tran, T, McClure, M, Frye, C, Hattier, T, Phelps, R, Haugen-Strano, R, Katcher, H, Gholami, Z, Shaffer, D, Stone, S, Bayer, S, Wray, C, Bogden, R, Dayananth, P, Ward, J, Tonin, P, Narod, S, Bristow, PK, Norris, FH, Helvering, L, Morrison, P, Rosteck, P, Lai, M, Barrett, JC, Lewis, C, Neuhausen, S, Cannon-Albright, L, Goldgar, D, Wiseman, R, Kamb, A & Skolnick, MHA (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
Picado-Leonard, J & Miller, WL (1987). Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20-lyase): similarity with the gene for P450c21. DNA 6: 5 439–448.
Thorlacius, S, Olafsdottir, G, Tryggvadottir, L, Neuhausen, S, Jonasson, JG, Tavtigian, S, Tulinius, H, Ögmundsdottir, HM & Eyfjörd, JE (1996). A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13: 117–119.
Wooster, R, Mangion, J, Eeles, R, Smith, S, Mitchell, D, Averill, D, Barrett-Lee, P, Easton, DF, Ponder, BAJP & Stratton, MR (1992). A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2: 2132–134.
Wooster, R, Bignell, G, Lancaster, J, Swift, S, Seal, S, Mangion, J, Collins, N, Gregory, S, Gumbs, C, Micklem, G, Barfoot, R, Hamoudi, R, Patel, S, Rice, C, Biggs, P, Hashim, Y, Smith, A, Connor, F, Arason, A, Gudmundsson, J, Ficenec, D, Kelsell, D, Ford, D, Tonin, P, Bishop, DT, Spurr, NK, Ponder, BAJP, Eeles, R, Peto, J, Devilee, P, Cornelisse, C, Lynch, H, Narod, S, Lenoir, G, Egilsson, V, Barkadottir, RB, Easton, DF, Bentley, DR, Futreal, PA, Ashworth, A & Stratton, MR (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Young, I., Kurian, K., Annink, C. et al. A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81, 141–143 (1999). https://doi.org/10.1038/sj.bjc.6690663
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690663
Keywords
This article is cited by
-
Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
Egyptian Journal of Medical Human Genetics (2019)
-
Male breast cancer: a disease distinct from female breast cancer
Breast Cancer Research and Treatment (2019)
-
Cancer du sein chez l’homme : ce qui différencie les hommes des femmes
Psycho-Oncologie (2017)
-
The CYP17-MspA1 rs743572 polymorphism is not associated with gender dysphoria
Genes & Genomics (2016)
-
The Epidemiology of Male Breast Cancer
Current Oncology Reports (2016)
